Outlook Therapeutics, Inc. (OTLK)
NASDAQ·Healthcare·Biotechnology
$0.67
-3.63%
Mkt Cap $126.58M
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (4 analysts)
$2.80
Range $1.60 – $4.00
Implied Upside
+317.3%
Consensus $2.80 vs current $0.67
NASDAQ·Healthcare·Biotechnology
$0.67
-3.63%
Mkt Cap $126.58M
Buy
4
Hold
2
Sell
0
Price Target (4 analysts)
$2.80
Range $1.60 – $4.00
+317.3%
Consensus $2.80 vs current $0.67